Cite
HARVARD Citation
Garcia-Vidal, C. et al. (2021). Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. Journal of antimicrobial chemotherapy. pp. 3296-3302. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Garcia-Vidal, C. et al. (2021). Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19. Journal of antimicrobial chemotherapy. pp. 3296-3302. [Online].